APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nuclear Receptor ROR-Gamma

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nuclear Receptor ROR-Gamma Industry Growth and Trends Forecast to 2032

19 December 2025124 pages

Choose your research edition.

Industry ResearchNuclear Receptor ROR-Gamma Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Nuclear Receptor ROR-Gamma Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Nuclear Receptor ROR-Gamma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nuclear Receptor ROR-Gamma Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Nuclear Receptor ROR-Gamma Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

According to APO Research, the global Nuclear Receptor ROR-Gamma market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nuclear Receptor ROR-Gamma is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nuclear Receptor ROR-Gamma is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nuclear Receptor ROR-Gamma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Nuclear Receptor ROR-Gamma market include 4SC AG, Vitae Pharmaceuticals, Inc., Visionary Pharmaceuticals, Inc., Teijin Pharma Limited, Reata Pharmaceuticals, Inc., Phenex Pharmaceuticals AG, Nuevolution AB, Lead Pharma Holding B.V. and Karo Bio AB, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nuclear Receptor ROR-Gamma market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nuclear Receptor ROR-Gamma market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nuclear Receptor ROR-Gamma market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nuclear Receptor ROR-Gamma.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Nuclear Receptor ROR-Gamma market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nuclear Receptor ROR-Gamma Market by Company

4SC AG

Vitae Pharmaceuticals, Inc.

Visionary Pharmaceuticals, Inc.

Teijin Pharma Limited

Reata Pharmaceuticals, Inc.

Phenex Pharmaceuticals AG

Nuevolution AB

Lead Pharma Holding B.V.

Karo Bio AB

Hanmi Pharmaceuticals, Co. Ltd.

GlaxoSmithKline Plc

Genfit SA

Genentech, Inc.

Celgene Corporation

Bristol-Myers Squibb Company

Brickell Biotech, Inc.

Biogen, Inc.

Aurigene Discovery Technologies Limited

Arrien Pharmaceuticals, LLC

Advinus Therapeutics Ltd.

Nuclear Receptor ROR-Gamma Segment by Type

BBI-6000

GSK-2981278

INV-17

VPR-66

Others

Nuclear Receptor ROR-Gamma Segment by Application

Hospital

Clinic

Others

Nuclear Receptor ROR-Gamma Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Receptor ROR-Gamma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nuclear Receptor ROR-Gamma and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Receptor ROR-Gamma.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Nuclear Receptor ROR-Gamma companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Nuclear Receptor ROR-Gamma Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Nuclear Receptor ROR-Gamma Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Nuclear Receptor ROR-Gamma Market Share by Region (2021-2026) Table 4. Global Nuclear Receptor ROR-Gamma Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Nuclear Receptor ROR-Gamma Market Share by Region (2027-2032) Table 6. Global Nuclear Receptor ROR-Gamma Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Nuclear Receptor ROR-Gamma Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Nuclear Receptor ROR-Gamma Market Size Share by Type (2021-2026) Table 9. Global Nuclear Receptor ROR-Gamma Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Nuclear Receptor ROR-Gamma Market Size Share Forecasted by Type (2027-2032) Table 11. North America Nuclear Receptor ROR-Gamma Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Nuclear Receptor ROR-Gamma Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Nuclear Receptor ROR-Gamma Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Nuclear Receptor ROR-Gamma Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Nuclear Receptor ROR-Gamma Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Nuclear Receptor ROR-Gamma Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Nuclear Receptor ROR-Gamma Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Nuclear Receptor ROR-Gamma Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Nuclear Receptor ROR-Gamma Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Nuclear Receptor ROR-Gamma Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Nuclear Receptor ROR-Gamma Market Size Share by Application (2021-2026) Table 24. Global Nuclear Receptor ROR-Gamma Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Nuclear Receptor ROR-Gamma Market Size Share Forecasted by Application (2027-2032) Table 26. North America Nuclear Receptor ROR-Gamma Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Nuclear Receptor ROR-Gamma Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Nuclear Receptor ROR-Gamma Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Nuclear Receptor ROR-Gamma Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Nuclear Receptor ROR-Gamma Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Nuclear Receptor ROR-Gamma Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Nuclear Receptor ROR-Gamma Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Nuclear Receptor ROR-Gamma Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Nuclear Receptor ROR-Gamma Industry Trends Table 37. Nuclear Receptor ROR-Gamma Industry Drivers Table 38. Nuclear Receptor ROR-Gamma Industry Opportunities and Challenges Table 39. Nuclear Receptor ROR-Gamma Industry Restraints Table 40. Global Nuclear Receptor ROR-Gamma Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Company (2021-2026) Table 42. Global Nuclear Receptor ROR-Gamma Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Nuclear Receptor ROR-Gamma Key Company Headquarters & Area Served Table 44. Global Nuclear Receptor ROR-Gamma Company, Product Type & Application Table 45. Global Nuclear Receptor ROR-Gamma Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Nuclear Receptor ROR-Gamma by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. 4SC AG Company Information Table 49. 4SC AG Business Overview Table 50. 4SC AG Nuclear Receptor ROR-Gamma Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. 4SC AG Nuclear Receptor ROR-Gamma Product Portfolio Table 52. 4SC AG Recent Development Table 53. Vitae Pharmaceuticals, Inc. Company Information Table 54. Vitae Pharmaceuticals, Inc. Business Overview Table 55. Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Portfolio Table 57. Vitae Pharmaceuticals, Inc. Recent Development Table 58. Visionary Pharmaceuticals, Inc. Company Information Table 59. Visionary Pharmaceuticals, Inc. Business Overview Table 60. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Portfolio Table 62. Visionary Pharmaceuticals, Inc. Recent Development Table 63. Teijin Pharma Limited Company Information Table 64. Teijin Pharma Limited Business Overview Table 65. Teijin Pharma Limited Nuclear Receptor ROR-Gamma Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product Portfolio Table 67. Teijin Pharma Limited Recent Development Table 68. Reata Pharmaceuticals, Inc. Company Information Table 69. Reata Pharmaceuticals, Inc. Business Overview Table 70. Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Portfolio Table 72. Reata Pharmaceuticals, Inc. Recent Development Table 73. Phenex Pharmaceuticals AG Company Information Table 74. Phenex Pharmaceuticals AG Business Overview Table 75. Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product Portfolio Table 77. Phenex Pharmaceuticals AG Recent Development Table 78. Nuevolution AB Company Information Table 79. Nuevolution AB Business Overview Table 80. Nuevolution AB Nuclear Receptor ROR-Gamma Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Nuevolution AB Nuclear Receptor ROR-Gamma Product Portfolio Table 82. Nuevolution AB Recent Development Table 83. Lead Pharma Holding B.V. Company Information Table 84. Lead Pharma Holding B.V. Business Overview Table 85. Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Product Portfolio Table 87. Lead Pharma Holding B.V. Recent Development Table 88. Karo Bio AB Company Information Table 89. Karo Bio AB Business Overview Table 90. Karo Bio AB Nuclear Receptor ROR-Gamma Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Karo Bio AB Nuclear Receptor ROR-Gamma Product Portfolio Table 92. Karo Bio AB Recent Development Table 93. Hanmi Pharmaceuticals, Co. Ltd. Company Information Table 94. Hanmi Pharmaceuticals, Co. Ltd. Business Overview Table 95. Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Product Portfolio Table 97. Hanmi Pharmaceuticals, Co. Ltd. Recent Development Table 98. GlaxoSmithKline Plc Company Information Table 99. GlaxoSmithKline Plc Business Overview Table 100. GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product Portfolio Table 102. GlaxoSmithKline Plc Recent Development Table 103. Genfit SA Company Information Table 104. Genfit SA Business Overview Table 105. Genfit SA Nuclear Receptor ROR-Gamma Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Genfit SA Nuclear Receptor ROR-Gamma Product Portfolio Table 107. Genfit SA Recent Development Table 108. Genentech, Inc. Company Information Table 109. Genentech, Inc. Business Overview Table 110. Genentech, Inc. Nuclear Receptor ROR-Gamma Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Genentech, Inc. Nuclear Receptor ROR-Gamma Product Portfolio Table 112. Genentech, Inc. Recent Development Table 113. Celgene Corporation Company Information Table 114. Celgene Corporation Business Overview Table 115. Celgene Corporation Nuclear Receptor ROR-Gamma Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Celgene Corporation Nuclear Receptor ROR-Gamma Product Portfolio Table 117. Celgene Corporation Recent Development Table 118. Bristol-Myers Squibb Company Company Information Table 119. Bristol-Myers Squibb Company Business Overview Table 120. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product Portfolio Table 122. Bristol-Myers Squibb Company Recent Development Table 123. Brickell Biotech, Inc. Company Information Table 124. Brickell Biotech, Inc. Business Overview Table 125. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Product Portfolio Table 127. Brickell Biotech, Inc. Recent Development Table 128. Biogen, Inc. Company Information Table 129. Biogen, Inc. Business Overview Table 130. Biogen, Inc. Nuclear Receptor ROR-Gamma Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Biogen, Inc. Nuclear Receptor ROR-Gamma Product Portfolio Table 132. Biogen, Inc. Recent Development Table 133. Aurigene Discovery Technologies Limited Company Information Table 134. Aurigene Discovery Technologies Limited Business Overview Table 135. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product Portfolio Table 137. Aurigene Discovery Technologies Limited Recent Development Table 138. Arrien Pharmaceuticals, LLC Company Information Table 139. Arrien Pharmaceuticals, LLC Business Overview Table 140. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product Portfolio Table 142. Arrien Pharmaceuticals, LLC Recent Development Table 143. Advinus Therapeutics Ltd. Company Information Table 144. Advinus Therapeutics Ltd. Business Overview Table 145. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Product Portfolio Table 147. Advinus Therapeutics Ltd. Recent Development Table 148. North America Nuclear Receptor ROR-Gamma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Nuclear Receptor ROR-Gamma Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Nuclear Receptor ROR-Gamma Market Share by Country (2021-2026) Table 151. North America Nuclear Receptor ROR-Gamma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Nuclear Receptor ROR-Gamma Market Share Forecast by Country (2027-2032) Table 153. Europe Nuclear Receptor ROR-Gamma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Nuclear Receptor ROR-Gamma Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Nuclear Receptor ROR-Gamma Market Share by Country (2021-2026) Table 156. Europe Nuclear Receptor ROR-Gamma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Nuclear Receptor ROR-Gamma Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Nuclear Receptor ROR-Gamma Market Share by Country (2021-2026) Table 161. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Nuclear Receptor ROR-Gamma Market Share Forecast by Country (2027-2032) Table 163. Latin America Nuclear Receptor ROR-Gamma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Nuclear Receptor ROR-Gamma Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Nuclear Receptor ROR-Gamma Market Share by Country (2021-2026) Table 166. Latin America Nuclear Receptor ROR-Gamma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Nuclear Receptor ROR-Gamma Market Share Forecast by Country (2027-2032) Table 168. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East & Africa Nuclear Receptor ROR-Gamma Market Share by Country (2021-2026) Table 171. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East & Africa Nuclear Receptor ROR-Gamma Market Share Forecast by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Nuclear Receptor ROR-Gamma Product Image Figure 3. Global Nuclear Receptor ROR-Gamma Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 5. Global Nuclear Receptor ROR-Gamma Market Share by Region: 2025 VS 2032 Figure 6. Global Nuclear Receptor ROR-Gamma Market Share by Region (2021-2032) Figure 7. North America Nuclear Receptor ROR-Gamma Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Nuclear Receptor ROR-Gamma Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Nuclear Receptor ROR-Gamma Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. BBI-6000 Image Figure 13. Global BBI-6000 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. GSK-2981278 Image Figure 15. Global GSK-2981278 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. INV-17 Image Figure 17. Global INV-17 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. VPR-66 Image Figure 19. Global VPR-66 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Nuclear Receptor ROR-Gamma Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Nuclear Receptor ROR-Gamma Market Share by Type 2025 VS 2032 Figure 24. North America Nuclear Receptor ROR-Gamma Market Size Share by Type (2021-2032) Figure 25. Europe Nuclear Receptor ROR-Gamma Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size Share by Type (2021-2032) Figure 27. Latin America Nuclear Receptor ROR-Gamma Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Nuclear Receptor ROR-Gamma Market Size Share by Type (2021-2032) Figure 29. Hospital Image Figure 30. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Clinic Image Figure 32. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Nuclear Receptor ROR-Gamma Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Nuclear Receptor ROR-Gamma Market Share by Application 2025 VS 2032 Figure 37. North America Nuclear Receptor ROR-Gamma Market Size Share by Application (2021-2032) Figure 38. Europe Nuclear Receptor ROR-Gamma Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size Share by Application (2021-2032) Figure 40. Latin America Nuclear Receptor ROR-Gamma Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Nuclear Receptor ROR-Gamma Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Nuclear Receptor ROR-Gamma Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Nuclear Receptor ROR-Gamma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Nuclear Receptor ROR-Gamma Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Nuclear Receptor ROR-Gamma Market Share by Country (2021-2032) Figure 47. Europe Nuclear Receptor ROR-Gamma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Nuclear Receptor ROR-Gamma Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Nuclear Receptor ROR-Gamma Market Share by Country (2021-2032) Figure 50. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Nuclear Receptor ROR-Gamma Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Nuclear Receptor ROR-Gamma Market Share by Country (2021-2032) Figure 53. Latin America Nuclear Receptor ROR-Gamma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Nuclear Receptor ROR-Gamma Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Nuclear Receptor ROR-Gamma Market Share by Country (2021-2032) Figure 56. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Nuclear Receptor ROR-Gamma Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Nuclear Receptor ROR-Gamma Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • BBI-6000
  • GSK-2981278
  • INV-17
  • VPR-66
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • 4SC AG
  • Vitae Pharmaceuticals, Inc.
  • Visionary Pharmaceuticals, Inc.
  • Teijin Pharma Limited
  • Reata Pharmaceuticals, Inc.
  • Phenex Pharmaceuticals AG
  • Nuevolution AB
  • Lead Pharma Holding B.V.
  • Karo Bio AB
  • Hanmi Pharmaceuticals, Co. Ltd.
  • GlaxoSmithKline Plc
  • Genfit SA
  • Genentech, Inc.
  • Celgene Corporation
  • Bristol-Myers Squibb Company
  • Brickell Biotech, Inc.
  • Biogen, Inc.
  • Aurigene Discovery Technologies Limited
  • Arrien Pharmaceuticals, LLC
  • Advinus Therapeutics Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Nuclear Receptor ROR-Gamma Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Nuclear Receptor ROR-Gamma Market Size by Region (2021-2032)
  5. 1.4.1 Global Nuclear Receptor ROR-Gamma Market Size by Region (2021-2026)
  6. 1.4.2 Global Nuclear Receptor ROR-Gamma Market Size by Region (2027-2032)
  7. 1.5 Key Regions Nuclear Receptor ROR-Gamma Market Size (2021-2032)
  8. 1.5.1 North America Nuclear Receptor ROR-Gamma Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Nuclear Receptor ROR-Gamma Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Nuclear Receptor ROR-Gamma Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size Growth Rate (2021-2032)
2 Nuclear Receptor ROR-Gamma Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 BBI-6000
  3. 2.1.2 GSK-2981278
  4. 2.1.3 INV-17
  5. 2.1.4 VPR-66
  6. 2.1.5 Others
  7. 2.2 Global Nuclear Receptor ROR-Gamma Market Size by Type
  8. 2.2.1 Global Nuclear Receptor ROR-Gamma Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Nuclear Receptor ROR-Gamma Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Nuclear Receptor ROR-Gamma Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Nuclear Receptor ROR-Gamma Market Size by Regions
  12. 2.3.1 North America Nuclear Receptor ROR-Gamma Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Nuclear Receptor ROR-Gamma Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Nuclear Receptor ROR-Gamma Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Nuclear Receptor ROR-Gamma Market Size Breakdown by Type (2021-2026)
3 Nuclear Receptor ROR-Gamma Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Others
  5. 3.2 Global Nuclear Receptor ROR-Gamma Market Size by Application
  6. 3.2.1 Global Nuclear Receptor ROR-Gamma Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Nuclear Receptor ROR-Gamma Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Nuclear Receptor ROR-Gamma Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Nuclear Receptor ROR-Gamma Market Size by Regions
  10. 3.3.1 North America Nuclear Receptor ROR-Gamma Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Nuclear Receptor ROR-Gamma Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Nuclear Receptor ROR-Gamma Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Nuclear Receptor ROR-Gamma Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Nuclear Receptor ROR-Gamma Industry Trends
  2. 4.2 Nuclear Receptor ROR-Gamma Industry Drivers
  3. 4.3 Nuclear Receptor ROR-Gamma Industry Opportunities and Challenges
  4. 4.4 Nuclear Receptor ROR-Gamma Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Nuclear Receptor ROR-Gamma Revenue (2021-2026)
  2. 5.2 Global Nuclear Receptor ROR-Gamma Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Nuclear Receptor ROR-Gamma Key Company Headquarters & Area Served
  4. 5.4 Global Nuclear Receptor ROR-Gamma Company, Product Type & Application
  5. 5.5 Global Nuclear Receptor ROR-Gamma Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Nuclear Receptor ROR-Gamma Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Nuclear Receptor ROR-Gamma Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Nuclear Receptor ROR-Gamma Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 4SC AG
  2. 6.1.1 4SC AG Company Information
  3. 6.1.2 4SC AG Business Overview
  4. 6.1.3 4SC AG Nuclear Receptor ROR-Gamma Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 4SC AG Nuclear Receptor ROR-Gamma Product Portfolio
  6. 6.1.5 4SC AG Recent Developments
  7. 6.2 Vitae Pharmaceuticals, Inc.
  8. 6.2.1 Vitae Pharmaceuticals, Inc. Company Information
  9. 6.2.2 Vitae Pharmaceuticals, Inc. Business Overview
  10. 6.2.3 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Portfolio
  12. 6.2.5 Vitae Pharmaceuticals, Inc. Recent Developments
  13. 6.3 Visionary Pharmaceuticals, Inc.
  14. 6.3.1 Visionary Pharmaceuticals, Inc. Company Information
  15. 6.3.2 Visionary Pharmaceuticals, Inc. Business Overview
  16. 6.3.3 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Portfolio
  18. 6.3.5 Visionary Pharmaceuticals, Inc. Recent Developments
  19. 6.4 Teijin Pharma Limited
  20. 6.4.1 Teijin Pharma Limited Company Information
  21. 6.4.2 Teijin Pharma Limited Business Overview
  22. 6.4.3 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product Portfolio
  24. 6.4.5 Teijin Pharma Limited Recent Developments
  25. 6.5 Reata Pharmaceuticals, Inc.
  26. 6.5.1 Reata Pharmaceuticals, Inc. Company Information
  27. 6.5.2 Reata Pharmaceuticals, Inc. Business Overview
  28. 6.5.3 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Portfolio
  30. 6.5.5 Reata Pharmaceuticals, Inc. Recent Developments
  31. 6.6 Phenex Pharmaceuticals AG
  32. 6.6.1 Phenex Pharmaceuticals AG Company Information
  33. 6.6.2 Phenex Pharmaceuticals AG Business Overview
  34. 6.6.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product Portfolio
  36. 6.6.5 Phenex Pharmaceuticals AG Recent Developments
  37. 6.7 Nuevolution AB
  38. 6.7.1 Nuevolution AB Company Information
  39. 6.7.2 Nuevolution AB Business Overview
  40. 6.7.3 Nuevolution AB Nuclear Receptor ROR-Gamma Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Nuevolution AB Nuclear Receptor ROR-Gamma Product Portfolio
  42. 6.7.5 Nuevolution AB Recent Developments
  43. 6.8 Lead Pharma Holding B.V.
  44. 6.8.1 Lead Pharma Holding B.V. Company Information
  45. 6.8.2 Lead Pharma Holding B.V. Business Overview
  46. 6.8.3 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Product Portfolio
  48. 6.8.5 Lead Pharma Holding B.V. Recent Developments
  49. 6.9 Karo Bio AB
  50. 6.9.1 Karo Bio AB Company Information
  51. 6.9.2 Karo Bio AB Business Overview
  52. 6.9.3 Karo Bio AB Nuclear Receptor ROR-Gamma Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Karo Bio AB Nuclear Receptor ROR-Gamma Product Portfolio
  54. 6.9.5 Karo Bio AB Recent Developments
  55. 6.10 Hanmi Pharmaceuticals, Co. Ltd.
  56. 6.10.1 Hanmi Pharmaceuticals, Co. Ltd. Company Information
  57. 6.10.2 Hanmi Pharmaceuticals, Co. Ltd. Business Overview
  58. 6.10.3 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Product Portfolio
  60. 6.10.5 Hanmi Pharmaceuticals, Co. Ltd. Recent Developments
  61. 6.11 GlaxoSmithKline Plc
  62. 6.11.1 GlaxoSmithKline Plc Company Information
  63. 6.11.2 GlaxoSmithKline Plc Business Overview
  64. 6.11.3 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product Portfolio
  66. 6.11.5 GlaxoSmithKline Plc Recent Developments
  67. 6.12 Genfit SA
  68. 6.12.1 Genfit SA Company Information
  69. 6.12.2 Genfit SA Business Overview
  70. 6.12.3 Genfit SA Nuclear Receptor ROR-Gamma Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Genfit SA Nuclear Receptor ROR-Gamma Product Portfolio
  72. 6.12.5 Genfit SA Recent Developments
  73. 6.13 Genentech, Inc.
  74. 6.13.1 Genentech, Inc. Company Information
  75. 6.13.2 Genentech, Inc. Business Overview
  76. 6.13.3 Genentech, Inc. Nuclear Receptor ROR-Gamma Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Genentech, Inc. Nuclear Receptor ROR-Gamma Product Portfolio
  78. 6.13.5 Genentech, Inc. Recent Developments
  79. 6.14 Celgene Corporation
  80. 6.14.1 Celgene Corporation Company Information
  81. 6.14.2 Celgene Corporation Business Overview
  82. 6.14.3 Celgene Corporation Nuclear Receptor ROR-Gamma Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Celgene Corporation Nuclear Receptor ROR-Gamma Product Portfolio
  84. 6.14.5 Celgene Corporation Recent Developments
  85. 6.15 Bristol-Myers Squibb Company
  86. 6.15.1 Bristol-Myers Squibb Company Company Information
  87. 6.15.2 Bristol-Myers Squibb Company Business Overview
  88. 6.15.3 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product Portfolio
  90. 6.15.5 Bristol-Myers Squibb Company Recent Developments
  91. 6.16 Brickell Biotech, Inc.
  92. 6.16.1 Brickell Biotech, Inc. Company Information
  93. 6.16.2 Brickell Biotech, Inc. Business Overview
  94. 6.16.3 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Product Portfolio
  96. 6.16.5 Brickell Biotech, Inc. Recent Developments
  97. 6.17 Biogen, Inc.
  98. 6.17.1 Biogen, Inc. Company Information
  99. 6.17.2 Biogen, Inc. Business Overview
  100. 6.17.3 Biogen, Inc. Nuclear Receptor ROR-Gamma Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Biogen, Inc. Nuclear Receptor ROR-Gamma Product Portfolio
  102. 6.17.5 Biogen, Inc. Recent Developments
  103. 6.18 Aurigene Discovery Technologies Limited
  104. 6.18.1 Aurigene Discovery Technologies Limited Company Information
  105. 6.18.2 Aurigene Discovery Technologies Limited Business Overview
  106. 6.18.3 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product Portfolio
  108. 6.18.5 Aurigene Discovery Technologies Limited Recent Developments
  109. 6.19 Arrien Pharmaceuticals, LLC
  110. 6.19.1 Arrien Pharmaceuticals, LLC Company Information
  111. 6.19.2 Arrien Pharmaceuticals, LLC Business Overview
  112. 6.19.3 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product Portfolio
  114. 6.19.5 Arrien Pharmaceuticals, LLC Recent Developments
  115. 6.20 Advinus Therapeutics Ltd.
  116. 6.20.1 Advinus Therapeutics Ltd. Company Information
  117. 6.20.2 Advinus Therapeutics Ltd. Business Overview
  118. 6.20.3 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Product Portfolio
  120. 6.20.5 Advinus Therapeutics Ltd. Recent Developments
7 North America
  1. 7.1 North America Nuclear Receptor ROR-Gamma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Nuclear Receptor ROR-Gamma Market Size by Country (2021-2026)
  3. 7.3 North America Nuclear Receptor ROR-Gamma Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Nuclear Receptor ROR-Gamma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Nuclear Receptor ROR-Gamma Market Size by Country (2021-2026)
  3. 8.3 Europe Nuclear Receptor ROR-Gamma Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Nuclear Receptor ROR-Gamma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Nuclear Receptor ROR-Gamma Market Size by Country (2021-2026)
  3. 10.3 South America Nuclear Receptor ROR-Gamma Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst